131 related articles for article (PubMed ID: 34817173)
1. Identification of Highly Selective Orexin 1 Receptor Antagonists Driven by Structure-Based Design.
Lessel U; Ferrara M; Heine N; Marelli C; Carrettoni L; Pfau R; Schmidt E; Riether D
J Chem Inf Model; 2021 Dec; 61(12):5893-5905. PubMed ID: 34817173
[TBL] [Abstract][Full Text] [Related]
2. Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders.
Bonifazi A; Del Bello F; Giorgioni G; Piergentili A; Saab E; Botticelli L; Cifani C; Micioni Di Bonaventura E; Micioni Di Bonaventura MV; Quaglia W
Med Res Rev; 2023 Sep; 43(5):1607-1667. PubMed ID: 37036052
[TBL] [Abstract][Full Text] [Related]
3. Discovery of Nivasorexant (ACT-539313): The First Selective Orexin-1 Receptor Antagonist (SO1RA) Investigated in Clinical Trials.
Williams JT; Bolli MH; Brotschi C; Sifferlen T; Steiner MA; Treiber A; Gatfield J; Boss C
J Med Chem; 2024 Feb; 67(4):2337-2348. PubMed ID: 38331429
[TBL] [Abstract][Full Text] [Related]
4. In vivo microdialysis reveals that blockade of accumbal orexin OX
Kawashima H; Aono Y; Watanabe Y; Waddington JL; Saigusa T
Eur J Neurosci; 2022 Feb; 55(3):733-745. PubMed ID: 34989064
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of a novel potent, selective, and orally active orexin 2 receptor antagonist, SDM-878.
Maehara S; Yuge N; Higashi C; Ota T; Furukawa J; Takeuchi T
Neuropsychopharmacol Rep; 2020 Jun; 40(2):182-189. PubMed ID: 32337858
[TBL] [Abstract][Full Text] [Related]
6. Orexins modulate the growth of cultured rat adrenocortical cells, acting through type 1 and type 2 receptors coupled to the MAPK p42/p44- and p38-dependent cascades.
Spinazzi R; Ziolkowska A; Neri G; Nowak M; Rebuffat P; Nussdorfer GG; Andreis PG; Malendowicz LK
Int J Mol Med; 2005 May; 15(5):847-52. PubMed ID: 15806308
[TBL] [Abstract][Full Text] [Related]
7. Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX1) receptors, with downstream 5-HT2C receptor involvement.
Duxon MS; Stretton J; Starr K; Jones DN; Holland V; Riley G; Jerman J; Brough S; Smart D; Johns A; Chan W; Porter RA; Upton N
Psychopharmacology (Berl); 2001 Jan; 153(2):203-9. PubMed ID: 11205420
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Highly Potent Dual Orexin Receptor Antagonists via a Scaffold-Hopping Approach.
Heidmann B; Gatfield J; Roch C; Treiber A; Tortoioli S; Brotschi C; Williams JT; Bolli MH; Abele S; Sifferlen T; Jenck F; Boss C
ChemMedChem; 2016 Oct; 11(19):2132-2146. PubMed ID: 27390287
[TBL] [Abstract][Full Text] [Related]
9. Orexins stimulate glucocorticoid secretion from cultured rat and human adrenocortical cells, exclusively acting via the OX1 receptor.
Ziolkowska A; Spinazzi R; Albertin G; Nowak M; Malendowicz LK; Tortorella C; Nussdorfer GG
J Steroid Biochem Mol Biol; 2005 Sep; 96(5):423-9. PubMed ID: 16157481
[TBL] [Abstract][Full Text] [Related]
10. Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors.
Yin J; Babaoglu K; Brautigam CA; Clark L; Shao Z; Scheuermann TH; Harrell CM; Gotter AL; Roecker AJ; Winrow CJ; Renger JJ; Coleman PJ; Rosenbaum DM
Nat Struct Mol Biol; 2016 Apr; 23(4):293-9. PubMed ID: 26950369
[TBL] [Abstract][Full Text] [Related]
11. Crucial role of the orexin-B C-terminus in the induction of OX1 receptor-mediated apoptosis: analysis by alanine scanning, molecular modelling and site-directed mutagenesis.
Nicole P; Couvineau P; Jamin N; Voisin T; Couvineau A
Br J Pharmacol; 2015 Nov; 172(21):5211-23. PubMed ID: 26282891
[TBL] [Abstract][Full Text] [Related]
12. The Subthalamic Neurons are Activated by Both Orexin-A and Orexin-B.
Sheng Q; Xue Y; Wang Y; Chen AQ; Liu C; Liu YH; Chu HY; Chen L
Neuroscience; 2018 Jan; 369():97-108. PubMed ID: 29138106
[TBL] [Abstract][Full Text] [Related]
13. Study of human Orexin-1 and -2 G-protein-coupled receptors with novel and published antagonists by modeling, molecular dynamics simulations, and site-directed mutagenesis.
Heifetz A; Morris GB; Biggin PC; Barker O; Fryatt T; Bentley J; Hallett D; Manikowski D; Pal S; Reifegerste R; Slack M; Law R
Biochemistry; 2012 Apr; 51(15):3178-97. PubMed ID: 22448975
[TBL] [Abstract][Full Text] [Related]
14. Orexin excites rat inferior vestibular nuclear neurons via co-activation of OX1 and OX 2 receptors.
Yu L; Zhang XY; Chen ZP; Zhuang QX; Zhu JN; Wang JJ
J Neural Transm (Vienna); 2015 Jun; 122(6):747-55. PubMed ID: 25371350
[TBL] [Abstract][Full Text] [Related]
15. OX2 orexin/hypocretin receptor signal transduction in recombinant Chinese hamster ovary cells.
Kukkonen JP
Cell Signal; 2016 Feb; 28(2):51-60. PubMed ID: 26582739
[TBL] [Abstract][Full Text] [Related]
16. Orexin Directly Enhances the Excitability of Globus Pallidus Internus Neurons in Rat by Co-activating OX1 and OX2 Receptors.
Gao HR; Zhuang QX; Zhang YX; Chen ZP; Li B; Zhang XY; Zhong YT; Wang JJ; Zhu JN
Neurosci Bull; 2017 Aug; 33(4):365-372. PubMed ID: 28389870
[TBL] [Abstract][Full Text] [Related]
17. Orexin A and B in vitro modify orexins receptors expression and gonadotropins secretion of anterior pituitary cells of proestrous rats.
Cataldi NI; Lux Lantos VA; Libertun C
Regul Pept; 2014 Jan; 188():25-30. PubMed ID: 24333629
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Evaluation of Orexin-1 Receptor Antagonists with Improved Solubility and CNS Permeability.
Perrey DA; Decker AM; Zhang Y
ACS Chem Neurosci; 2018 Mar; 9(3):587-602. PubMed ID: 29129052
[TBL] [Abstract][Full Text] [Related]
19. Orexin research: patent news from 2016.
Boss C; Roch C
Expert Opin Ther Pat; 2017 Oct; 27(10):1123-1133. PubMed ID: 28631980
[TBL] [Abstract][Full Text] [Related]
20. Therapeutics development for addiction: Orexin-1 receptor antagonists.
Perrey DA; Zhang Y
Brain Res; 2020 Mar; 1731():145922. PubMed ID: 30148984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
